Rockefeller Capital Management L.P. Intra Cellular Therapies, Inc. Transaction History

Rockefeller Capital Management L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 17, 2023	BUY	$43.8 - $56.99 $66,532 - $86,567	1,519 Added 42.6%	5,085 $275,000
Q4 2022 Mar 06, 2023	BUY	$44.07 - $54.45 $3,261 - $4,029	74 Added 2.12%	3,566 $188,000
Q3 2022 Nov 02, 2022	BUY	$42.7 - $59.99 $139,799 - $196,407	3,274 Added 1501.83%	3,492 $162,000
Q2 2022 Aug 12, 2022	BUY	$43.0 - $65.64 $8,256 - $12,602	192 Added 738.46%	218 $12,000
Q1 2022 May 13, 2022	BUY	$38.74 - $62.09 $1,007 - $1,614	26 New	26 $1,000

378

84.7M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.85B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.